Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Capital Goods
Create a narrative
Nordson
NasdaqGS:NDSN Community
Create a narrative
Nordson
Undervalued
Overvalued
Nordson
WA
Analyst Price Target
Consensus Narrative from 8 Analysts
Integration Of Atrion And Ascend Strategy Will Accelerate Growth In Medical And Electronics Markets
Key Takeaways Strategic acquisitions and operational efficiencies from the Ascend strategy and NBS Next are expected to drive consistent revenue growth and enhance margins. Expansion into high-growth markets like medical and electronics, combined with high-recurring revenue, supports increased revenue and market stability.
View narrative
US$255.82
FV
15.3% undervalued
intrinsic discount
5.39%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
NDSN
Nordson
Your Fair Value
US$
Current Price
US$216.66
5.1% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.6b
Earnings US$630.4m
Advanced
Set as Fair Value